Name and Address of Company

Eupraxia Pharmaceuticals Inc. (the "Company")

201-2067 Cadboro Bay Rd.

Victoria, British Columbia

Canada, V8R 5G4

Date of Material Change

April 5, 2024

News Release

A news release announcing the material change was issued on April 5, 2024 through Globe Newswire and a copy was subsequently filed on SEDAR+.

Summary of Material Change

On April 5, 2024, the Company announced that trading of the Company's common shares would begin on the Nasdaq Capital Market ("Nasdaq"), under the ticker symbol "EPRX".

Full Description of Material Change

On April 5, 2024, the Company announced that trading of the Company's common shares would begin on the Nasdaq, under the ticker symbol "EPRX". The Company's shares also continue to trade on the Toronto Stock Exchange under the ticker symbol "EPRX".

Disclosure of Restructuring Transactions

Not applicable.

Reliance on subsection 7.1(2) of National Instrument 51-102

Not applicable.

Omitted Information

Not applicable.

Executive Officer

For further information, please contact Bruce Cousins, President and Chief Financial Officer of the Company at 250-590-3968.

Date of Report

April 8, 2024

Attachments

  • Original Link
  • Permalink

Disclaimer

Eupraxia Pharmaceuticals Inc. published this content on 08 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 April 2024 20:28:16 UTC.